Cargando…
Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis
RAS-signaling mutations induce the myelomonocytic differentiation and proliferation of hematopoietic stem and progenitor cells. Moreover, they are important players in the development of myeloid neoplasias. RAF kinase inhibitor protein (RKIP) is a negative regulator of RAS-signaling. As RKIP loss ha...
Autores principales: | Caraffini, Veronica, Geiger, Olivia, Rosenberger, Angelika, Hatzl, Stefan, Perfler, Bianca, Berg, Johannes L., Lim, Clarice, Strobl, Herbert, Kashofer, Karl, Schauer, Silvia, Beham-Schmid, Christine, Hoefler, Gerald, Geissler, Klaus, Quehenberger, Franz, Kolch, Walter, Athineos, Dimitris, Blyth, Karen, Wölfler, Albert, Sill, Heinz, Zebisch, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012480/ https://www.ncbi.nlm.nih.gov/pubmed/31097632 http://dx.doi.org/10.3324/haematol.2018.209650 |
Ejemplares similares
-
RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019) -
Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing
por: Kashofer, Karl, et al.
Publicado: (2017) -
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia
por: Berg, Johannes Lorenz, et al.
Publicado: (2021) -
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity
por: Berg, Johannes Lorenz, et al.
Publicado: (2021) -
Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
por: Hatzl, Stefan, et al.
Publicado: (2020)